BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18288400)

  • 21. Effect of all-trans retinoic acid on drug sensitivity and expression of survivin in LoVo cells.
    Wei HB; Hu BG; Han XY; Zheng ZH; Wei B; Huang JL
    Chin Med J (Engl); 2008 Feb; 121(4):331-5. PubMed ID: 18304466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
    Huang ZG; Ran ZH; Lu W; Xiao SD
    Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retroviral endostatin gene transfer inhibits human colon cancer cell growth in vivo.
    Chen W; Fu J; Liu Q; Ruan C; Xiao S
    Chin Med J (Engl); 2003 Oct; 116(10):1582-4. PubMed ID: 14640106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.
    Ullmannova V; Popescu NC
    Int J Oncol; 2006 Nov; 29(5):1127-32. PubMed ID: 17016643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW; Yu X; Liu T; Yu SY; Chen DJ
    Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of TrkB promotes the progression of colon cancer.
    Yu Y; Zhang S; Wang X; Yang Z; Ou G
    APMIS; 2010 Mar; 118(3):188-95. PubMed ID: 20132184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin-1 activity of plasma membrane affects HT20 colon cancer cell migration.
    Jiang Y
    IUBMB Life; 2009 Oct; 61(10):1001-9. PubMed ID: 19787701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
    Liao YC; Lo SH
    Int J Biochem Cell Biol; 2008; 40(5):843-7. PubMed ID: 17521951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway.
    Holeiter G; Heering J; Erlmann P; Schmid S; Jähne R; Olayioye MA
    Cancer Res; 2008 Nov; 68(21):8743-51. PubMed ID: 18974116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth.
    Durkin ME; Ullmannova V; Guan M; Popescu NC
    Oncogene; 2007 Jul; 26(31):4580-9. PubMed ID: 17297465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of human colon carcinoma-associated fibroblasts on biological behavior of colon carcinoma Lovo cells].
    Wu XL; Lin KJ; Shi L; Su XL; Hou MX; Dong PD
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):759-63. PubMed ID: 23980048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.
    Liao YC; Shih YP; Lo SH
    Cancer Res; 2008 Oct; 68(19):7718-22. PubMed ID: 18829524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of RTKN on progression and metastasis of colon cancer in vitro.
    Qu GQ; Lu YM; Liu YF; Liu Y; Chen WX; Liao XH; Kong WM
    Biomed Pharmacother; 2015 Aug; 74():117-23. PubMed ID: 26349972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells.
    Hu LH; Yang JH; Zhang DT; Zhang S; Wang L; Cai PC; Zheng JF; Huang JS
    Anticancer Drugs; 2007 Apr; 18(4):427-33. PubMed ID: 17351395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells.
    Feng M; Huang B; Du Z; Xu X; Chen Z
    Mol Biol Rep; 2011 Mar; 38(3):1915-20. PubMed ID: 20882354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable RNA interference of hexokinase II gene inhibits human colon cancer LoVo cell growth in vitro and in vivo.
    Peng Q; Zhou Q; Zhou J; Zhong D; Pan F; Liang H
    Cancer Biol Ther; 2008 Jul; 7(7):1128-35. PubMed ID: 18535403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation.
    Liu H; Shi H; Hao Y; Zhao G; Yang X; Wang Y; Li M; Liu M
    Mol Biol Rep; 2012 Dec; 39(12):10665-70. PubMed ID: 23079702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and molecular characterization of the epithelioid to round transition in human colorectal cancer LoVo cells.
    Debruyne PR; Vermeulen SJ; Berx G; Pocard M; Correia da Rocha AS; Li X; Cirnes L; Poupon MF; van Roy FM; Mareel MM
    Oncogene; 2003 Oct; 22(46):7199-208. PubMed ID: 14562048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48.
    Dang LH; Chen F; Ying C; Chun SY; Knock SA; Appelman HD; Dang DT
    Oncogene; 2006 Apr; 25(15):2264-72. PubMed ID: 16314840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase-related protein VIII promotes colon cancer cell growth.
    Nishikata M; Nishimori I; Taniuchi K; Takeuchi T; Minakuchi T; Kohsaki T; Adachi Y; Ohtsuki Y; Onishi S
    Mol Carcinog; 2007 Mar; 46(3):208-14. PubMed ID: 17219437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.